[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_9952",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_9952"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB00059"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "oncaspar is an asparagine specific enzyme indicated as a component of a multi agent chemotherapeutic regimen for treatment of pediatric and adult patients with first line acute lymphoblastic leukemia 1 1 acute lymphoblastic leukemia and hypersensitivity to asparaginase 1 2 oncaspar r is indicated as a component of a multi agent chemotherapeutic regimen for the first line treatment of pediatric and adult patients with all oncaspar is indicated as a component of a multi agent chemotherapeutic regimen for the treatment of pediatric and adult patients with all and hypersensitivity to native forms of l asparaginase"
    } ],
    "https://w3id.org/biolink/vocab/association_type" : [ {
      "@id" : "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/TreatmentIndication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB00059",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-06-12T12:36:41.329+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
    } ]
  }, {
    "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "TZrR6w1Cpf/xIAHUVwPWmXRixKQag+djOzVFYmGNmOvAko6/xuuaUEhuTG8qArVrOf+9HMXzXkj5y2J+Dbf2fBkhvbBjU6l8VTnP5nWrPY8d8idL7maLUXplRmgKHh6tcevRW9ow6Y6co1t2mbUg3dal82I800BMae2Dxg7Lj6E="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ"
    } ]
  } ],
  "@id" : "http://purl.org/np/RACSiryP2eFJgDcSA8-CpxQzw4FZBXE9_TWPYGVLkQJsQ#pubinfo"
} ]